Dermatology for Practice, 2009, issue 3

Editorial

Proti stáří se bojovat nedá

prof. MUDr. Pavel Barták CSc

Dermatol. praxi. 2009;3(3):107  

Review articles

Current therapy of skin and mucosal mycoses

doc. RNDr. Vladimír Buchta CSc, doc. MUDr. Radovan Slezák CSc, doc. MUDr. Jiří Špaček, Ph.D, MUDr. Marie Košťálová, Ph.D, Mgr. Marcela Vejsková, doc. PharmDr. Martin Doležal Ph.D

Dermatol. praxi. 2009;3(3):109-118  

Superficial fungal infections are common, particularly dermatophytoses, onychomycoses, and vulvovaginal Candida infections. Most of these mycoses are treated with topical antimycotic drugs unless the infection involves an extensive area or is resistant to initial therapy. The use of griseofulvin in dermatology is limited to a few indications (tinea capitis in children), ketoconazole is replaced by other triazole drugs with a better pharmacological profile (no risk of idiopathic hepatitis) in most indications. Onychomycosis – one of the most difficultto- treat dermatomycosis largely requires systemic therapy with terbinafine or itraconazole...

The most frequent skin diseases in childhood and their therapy

MUDr. Štěpánka Čapková

Dermatol. praxi. 2009;3(3):119-124  

in offices of primary care pediatricians at least 20 % patients suffer from skin diseases. In last decades we observe an increase in allergic skin manifestations, constitutional dermatitis involves at least 5–15 % of pediatric population. Seborrheic dermatitis precedes frequently constitutional dermatitis already in first weeks of life. Preschool and school children with respect to their social contacts and numerous sport activities suffer by a number of skin infections, mainly impetigo. The most frequent skin disease of babies is surprisingly diaper dermatitis. The author summarizes clinical information about these diseases and discusses...

Pruritus - complete therapy

MUDr. Eva Jašková, MUDr. Petr Taraba

Dermatol. praxi. 2009;3(3):125-130  

Pruritus, one of the most often unpleasant sensationon on the skin, was originaly formed as a defensive mechanism. Dermatologists meet it in every day practice and for its therapy they need to have the knowledge of differential diagnosis skin diseases connected with itching as well as the knowledge of internal and psychiatric diseases with pruritus. The therapeutic palete of pruritus is wide according to etiology and not always efficient enough for us and for our patiens. It is the challenge for the further research of neurophysiology of pruritus and for searching other pharmacologic and non-pharmacologic possibilities for its control.

Interdisciplinary overviews

Vulvar diseases - part I

MUDr. Libor Ševčík, Ph.D, MUDr. Yvetta Vantuchová Ph.D

Dermatol. praxi. 2009;3(3):131-136  

Vulvar symptomatology manifested by vulvar discomfort in the form of itching, burning, cutting, and other sensations in the vulvar area, is the cause of chronic complaints in patients and a reason for repeated examinations by specialists – a gynaecologist and a dermatologist. The goal of a thorough examination which includes vulvoscopy with application of examination solution and obtaining biopsy samples is to determine the correct diagnosis with classifying the lesion into one of the five groups of vulvar diseases: vulvar dermatoses, vulvar intraepithelial neoplasias, neoplasias, infectious diseases, and vulvodynias. Issues related to vulvar...

Case report

Kaposi's sarcoma

MUDr. Zuzana Kudláčová, MUDr. Mária Rečková, MUDr. Dušan Pajerchin, MUDr. Juraj Beniak, MUDr. Mária Nováčeková

Dermatol. praxi. 2009;3(3):139-141  

The paper presents a case of a 76-year-old man with generalized cutaneous Kaposi's sarcoma. The patient was referred from a dermatology practice to our department in the disseminated stage of the disease in July 2006. Based on the clinical features, Kaposi's sarcoma (KS) was considered during differential diagnosis, however, the histological findings were nonspecific (a presentation of lymphocytic capillaritis). It was not until July 2007, when the patient was readmitted to our department for unresolving skin lesions, that the diagnosis was confirmed by a new histological examination of two biopsies. The above implies that skin manifestations of...

Cosmetic dermatology spot

Botulotoxin and his use in dermatology

MUDr. Zuzana Kulíková

Dermatol. praxi. 2009;3(3):136-138  

Botulinum toxin is a significant neurotoxin, which is produced by Clostridium botulinum bartery. Various species of this bartery produce eight subtypes of botulotoxin. Type A is the most used and researched to date, but is also the most toxic one. In dermatology, botulotoxin is used in two major indications, treatment of wrinkles and temporary decreasing focal hyperhidrosis.

Information

VIII. ročník Dermatologického semináře v Koutech n. Desnou

MUDr. Lubomír Drlík

Dermatol. praxi. 2009;3(3):141-142  

VI. ročník národní konference SAD v Pardubicích

MUDr. Petr Zajíc MBA

Dermatol. praxi. 2009;3(3):143  

Konference „Progress and promise: Changing practice, changing lives“ (Amsterdam, 26.- 28. 3. 2009)

doc. MUDr. Karel Ettler CSc

Dermatol. praxi. 2009;3(3):144-145  

První ročník konference Dermatologie pro praxi kladl důraz na praktickou část

Mgr. Michaela Majerová

Dermatol. praxi. 2009;3(3):149  

Abstracts

XII. olomoucká dermatologická konference, 20. března 2009 - Abstrakta

Dermatol. praxi. 2009;3(3):146-148  

Test

Autodidaktický test 3/2009

Dermatol. praxi. 2009;3(3):150  


Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.